Literature DB >> 2871874

Possible associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated male schizophrenics.

J G Csernansky, E Prosser, J Kaplan, E Mahler, P A Berger, L E Hollister.   

Abstract

To determine whether there is an association between prolactin (PRL) levels and psychopathology or tardive dyskinesia during neuroleptic treatment, we measured plasma prolactin levels and neuroleptic activity (NA) in 33 chronically treated male schizophrenics. Neuroleptic dose, plasma NA, and PRL were significantly intercorrelated. Plasma PRL levels were also measured in 8 male schizophrenics recently withdrawn from neuroleptics and in 18 normal male controls. In treated patients, but not in controls, PRL levels decreased with age and duration of illness, two variables that we interpreted as indirect measures of neuroleptic exposure. PRL levels in patients recently withdrawn from neuroleptics were lower than in treated patients or controls, which was suggestive of rebound hypoprolactinemia. A prolactin index, calculated as the ratio of PRL levels to NA, was inversely correlated with paranoid symptoms and tardive dyskinesia in younger treated patients. These results lead to speculation that tuberoinfundibular dopaminergic supersensitivity develops in chronically treated schizophrenics and that it is associated with nigrostriatal supersensitivity, manifested by tardive dyskinesia, and paranoid symptoms, which may reflect mesolimbic supersensitivity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871874     DOI: 10.1016/0006-3223(86)90124-1

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  4 in total

1.  [Female patient with depressive psychosis and visual disturbances].

Authors:  M Neubacher; M Reuter; K Hauenstein
Journal:  Radiologe       Date:  2013-08       Impact factor: 0.635

2.  Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinants.

Authors:  Hsien-Yuan Lane; Yue-Cune Chang; Chih-Chiang Chiu; Sue-Hong Lee; Cher-Yeang Lin; Wen-Ho Chang
Journal:  Psychopharmacology (Berl)       Date:  2003-12-09       Impact factor: 4.530

Review 3.  Prolactin and psychopathology in schizophrenia: a literature review and reappraisal.

Authors:  Ravi Philip Rajkumar
Journal:  Schizophr Res Treatment       Date:  2014-03-27

4.  Identifying dopamine supersensitivity through a randomized controlled study of switching to aripiprazole from other antipsychotic agents in patients with schizophrenia.

Authors:  Chia-Hao Ma; Hung-Yu Chan; Ming H Hsieh; Chen-Chung Liu; Chih-Min Liu; Hai-Gwo Hwu; Ching-Hua Kuo; Wei J Chen; Tzung-Jeng Hwang
Journal:  Ther Adv Psychopharmacol       Date:  2022-01-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.